Profiles

Keywords
Last Name
Institution

Annabelle Volgman

Concepts (349)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Atrial Fibrillation
24
2023
234
7.990
Why?
Cardiovascular Diseases
20
2023
446
5.440
Why?
Stroke
21
2023
405
4.480
Why?
Female
77
2023
18423
2.080
Why?
Anticoagulants
7
2022
153
2.050
Why?
Heart Failure
7
2022
241
1.920
Why?
Humans
99
2023
32988
1.910
Why?
Healthcare Disparities
6
2020
91
1.860
Why?
Coronary Artery Disease
8
2022
173
1.830
Why?
Myocardial Infarction
10
2022
194
1.750
Why?
Sex Factors
18
2022
548
1.750
Why?
Pregnancy Complications, Cardiovascular
6
2023
17
1.740
Why?
Risk Factors
30
2023
2762
1.630
Why?
Exercise
7
2022
494
1.510
Why?
Cardiology
5
2022
115
1.460
Why?
Risk Assessment
14
2022
814
1.420
Why?
Hospital Mortality
7
2022
197
1.410
Why?
Sex Characteristics
7
2023
139
1.410
Why?
Hospitalization
8
2021
367
1.350
Why?
Myocardial Ischemia
4
2022
64
1.350
Why?
Life Style
8
2020
226
1.340
Why?
Women's Health
4
2020
247
1.310
Why?
Aortic Valve Stenosis
3
2023
33
1.300
Why?
Transcatheter Aortic Valve Replacement
3
2023
33
1.300
Why?
Cardiovascular System
3
2022
15
1.280
Why?
Primary Prevention
4
2022
53
1.270
Why?
Physicians, Women
3
2022
19
1.200
Why?
Aged
40
2022
10542
1.200
Why?
Male
47
2023
17726
1.180
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2020
86
1.160
Why?
Catheter Ablation
3
2022
88
1.120
Why?
Pacemaker, Artificial
3
2023
52
1.120
Why?
United States
26
2023
2632
1.110
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2020
32
1.070
Why?
Adrenergic beta-Antagonists
2
2020
46
1.070
Why?
Health Status Disparities
4
2019
73
1.060
Why?
Arrhythmias, Cardiac
6
2019
172
1.030
Why?
Defibrillators, Implantable
3
2021
41
1.000
Why?
Anti-Arrhythmia Agents
7
2022
109
0.980
Why?
American Heart Association
4
2023
39
0.970
Why?
Ischemic Attack, Transient
2
2023
28
0.960
Why?
Middle Aged
32
2022
11219
0.920
Why?
Echocardiography, Doppler, Color
2
2019
15
0.900
Why?
Myocarditis
1
2022
8
0.890
Why?
Quality of Life
6
2023
747
0.890
Why?
Premature Birth
1
2022
7
0.890
Why?
Heart Defects, Congenital
1
2023
73
0.830
Why?
Coronavirus
1
2021
2
0.830
Why?
Pregnancy
9
2023
466
0.820
Why?
Electrocardiography
7
2015
230
0.810
Why?
Breast Neoplasms
3
2021
435
0.800
Why?
Length of Stay
4
2020
382
0.780
Why?
Chest Pain
1
2020
23
0.770
Why?
Endothelium
1
2020
13
0.760
Why?
Social Media
1
2021
37
0.760
Why?
Patient Care Management
2
2021
18
0.740
Why?
Brain Ischemia
1
2021
125
0.730
Why?
Vascular Diseases
1
2020
53
0.730
Why?
Takotsubo Cardiomyopathy
1
2019
20
0.720
Why?
Myxoma
1
2019
7
0.720
Why?
Ambulatory Care Facilities
2
2022
45
0.720
Why?
Cardiomyopathies
1
2019
38
0.710
Why?
Heart Neoplasms
1
2019
21
0.700
Why?
Heart Failure, Diastolic
1
2018
2
0.700
Why?
Comorbidity
5
2021
563
0.690
Why?
Women's Health Services
1
2018
12
0.690
Why?
Treatment Outcome
14
2023
4036
0.690
Why?
Age Factors
8
2021
932
0.680
Why?
Heart Diseases
1
2020
104
0.670
Why?
Culturally Competent Care
1
2018
12
0.670
Why?
Hypertension
7
2023
293
0.670
Why?
Prevalence
6
2020
554
0.670
Why?
Delivery of Health Care, Integrated
1
2018
31
0.670
Why?
Emigrants and Immigrants
1
2018
25
0.660
Why?
Coronavirus Infections
1
2020
96
0.650
Why?
Warfarin
3
2016
61
0.650
Why?
Pneumonia, Viral
1
2020
101
0.650
Why?
Heart Ventricles
1
2019
225
0.650
Why?
Antineoplastic Agents
1
2020
244
0.630
Why?
Atherosclerosis
1
2018
78
0.620
Why?
Lipoprotein(a)
1
2016
10
0.580
Why?
Cognition
3
2020
1325
0.560
Why?
Dyslipidemias
1
2016
28
0.560
Why?
Prognosis
7
2021
1011
0.550
Why?
Electrodes
1
2015
17
0.540
Why?
Diabetes Mellitus
3
2022
160
0.530
Why?
Secondary Prevention
3
2022
69
0.530
Why?
Health Knowledge, Attitudes, Practice
2
2022
233
0.530
Why?
Cost of Illness
1
2015
66
0.520
Why?
Social Support
1
2016
226
0.510
Why?
Electric Countershock
6
2020
30
0.490
Why?
Patient Readmission
3
2019
134
0.480
Why?
Aspirin
2
2020
96
0.480
Why?
Aortic Valve
3
2023
44
0.470
Why?
Magnetic Resonance Imaging
1
2019
1315
0.470
Why?
Aged, 80 and over
9
2021
5249
0.460
Why?
Retrospective Studies
10
2022
3835
0.430
Why?
Adult
14
2022
9848
0.430
Why?
Atrial Appendage
2
2022
53
0.420
Why?
Patient Acceptance of Health Care
1
2012
90
0.420
Why?
Coronary Angiography
3
2020
115
0.410
Why?
Alzheimer Disease
1
2023
1977
0.400
Why?
Acute Kidney Injury
2
2021
67
0.380
Why?
Cardiovascular Agents
2
2021
33
0.370
Why?
Cardiac Resynchronization Therapy Devices
2
2019
10
0.370
Why?
Cross-Sectional Studies
5
2022
1058
0.360
Why?
Hospital Costs
2
2020
74
0.360
Why?
Feasibility Studies
2
2020
282
0.350
Why?
Practice Guidelines as Topic
3
2021
388
0.320
Why?
Ventricular Fibrillation
2
2021
38
0.310
Why?
Percutaneous Coronary Intervention
3
2022
31
0.310
Why?
Heart Atria
2
2019
97
0.310
Why?
Administration, Oral
3
2016
158
0.270
Why?
Health Status
2
2018
247
0.270
Why?
Sex Distribution
3
2019
92
0.270
Why?
Randomized Controlled Trials as Topic
5
2020
377
0.270
Why?
Antihypertensive Agents
2
2020
93
0.260
Why?
Hemorrhage
5
2020
95
0.260
Why?
Societies, Medical
3
2023
214
0.260
Why?
Risk Adjustment
2
2021
14
0.260
Why?
Hospital Charges
2
2020
20
0.250
Why?
Incidence
4
2020
840
0.240
Why?
Logistic Models
3
2021
474
0.240
Why?
Obesity
4
2020
359
0.240
Why?
Illinois
2
2021
267
0.240
Why?
Cardiotoxicity
2
2020
5
0.240
Why?
Leadership
2
2022
112
0.240
Why?
Cohort Studies
4
2022
2077
0.240
Why?
Pulmonary Veins
1
2023
25
0.240
Why?
Age Distribution
2
2020
109
0.230
Why?
Maternal Mortality
1
2023
5
0.230
Why?
Cost-Benefit Analysis
2
2022
159
0.230
Why?
Morbidity
2
2019
72
0.230
Why?
Young Adult
3
2020
2287
0.230
Why?
Out-of-Hospital Cardiac Arrest
1
2022
5
0.230
Why?
Philippines
1
2022
5
0.220
Why?
Health Promotion
2
2016
188
0.220
Why?
Pregnancy Outcome
1
2022
22
0.220
Why?
Pregnant Women
1
2022
17
0.220
Why?
Cesarean Section
1
2022
34
0.220
Why?
Polypharmacy
1
2022
10
0.220
Why?
Vitamin K
1
2022
11
0.220
Why?
Attitude
1
2022
38
0.220
Why?
Sotalol
1
2021
11
0.220
Why?
Cardiac Electrophysiology
1
2021
3
0.210
Why?
Coronary Circulation
2
2020
49
0.210
Why?
Pandemics
2
2023
253
0.210
Why?
Troponin
1
2021
11
0.210
Why?
Venous Thromboembolism
1
2022
58
0.210
Why?
Shock, Cardiogenic
1
2021
11
0.210
Why?
Diagnostic Techniques, Cardiovascular
1
2021
4
0.210
Why?
Sexism
1
2021
9
0.210
Why?
Water-Electrolyte Imbalance
1
2021
3
0.210
Why?
Hormones
1
2021
18
0.210
Why?
Prospective Studies
3
2023
2002
0.210
Why?
Adolescent
2
2020
2687
0.210
Why?
Death, Sudden, Cardiac
1
2021
33
0.200
Why?
Women's Rights
1
2021
3
0.200
Why?
Overweight
1
2022
76
0.200
Why?
Alcohol Drinking
1
2022
88
0.200
Why?
Telemedicine
1
2023
117
0.200
Why?
National Institutes of Health (U.S.)
1
2021
35
0.200
Why?
Weight Loss
1
2022
116
0.200
Why?
Signal Processing, Computer-Assisted
2
1998
43
0.200
Why?
Angioplasty
1
2020
17
0.200
Why?
Health Expenditures
1
2020
19
0.200
Why?
Physician-Patient Relations
1
2021
47
0.200
Why?
Sleep Apnea, Obstructive
1
2022
79
0.200
Why?
Hyperlipidemias
1
2020
26
0.200
Why?
Career Choice
1
2021
34
0.200
Why?
Heart Valve Diseases
1
2020
33
0.200
Why?
Disease Outbreaks
1
2021
91
0.200
Why?
Postoperative Hemorrhage
1
2020
29
0.200
Why?
Periodicals as Topic
1
2021
47
0.190
Why?
Peripheral Arterial Disease
1
2020
24
0.190
Why?
Myocardial Revascularization
1
2020
25
0.190
Why?
Postnatal Care
1
2020
9
0.190
Why?
Accidental Falls
1
2022
118
0.190
Why?
Delivery, Obstetric
1
2020
15
0.190
Why?
Radiation-Protective Agents
1
2020
4
0.190
Why?
Colchicine
1
2020
9
0.190
Why?
Protective Factors
1
2020
19
0.190
Why?
Social Class
1
2020
77
0.190
Why?
After-Hours Care
1
2019
1
0.190
Why?
Income
1
2020
81
0.190
Why?
Endovascular Procedures
1
2020
84
0.180
Why?
Odds Ratio
2
2020
321
0.180
Why?
Prostatic Neoplasms
1
2021
125
0.180
Why?
Heart Valve Prosthesis Implantation
1
2020
53
0.180
Why?
Infant, Newborn
1
2022
761
0.180
Why?
Radiation Injuries
1
2020
44
0.180
Why?
Global Health
1
2019
61
0.180
Why?
Thrombolytic Therapy
1
2020
84
0.180
Why?
Clinical Trials as Topic
1
2021
368
0.180
Why?
Health Behavior
1
2020
181
0.180
Why?
Up-Regulation
2
2021
225
0.180
Why?
Cardiac Resynchronization Therapy
1
2019
24
0.180
Why?
Multimodal Imaging
1
2019
30
0.180
Why?
Heart
1
2019
119
0.170
Why?
Treatment Refusal
1
2018
14
0.170
Why?
Asia, Western
1
2018
2
0.170
Why?
Indian Ocean Islands
1
2018
2
0.170
Why?
Procainamide
1
1998
23
0.170
Why?
Heart Transplantation
1
1998
51
0.170
Why?
Atrial Flutter
1
1998
24
0.170
Why?
Graft Rejection
1
1998
87
0.170
Why?
Tachycardia
2
2021
49
0.170
Why?
Intensive Care Units
1
2021
339
0.160
Why?
Sulfonamides
1
1998
60
0.160
Why?
Walking
1
2020
277
0.160
Why?
Reproducibility of Results
3
2017
893
0.160
Why?
Memory Disorders
1
2019
181
0.160
Why?
Diagnosis, Differential
1
2019
462
0.160
Why?
Inpatients
1
2019
163
0.160
Why?
Coronary Disease
2
2020
101
0.160
Why?
Diet Surveys
1
2017
27
0.150
Why?
Patient Discharge
1
2018
169
0.150
Why?
Lupus Erythematosus, Systemic
1
2020
207
0.150
Why?
Pyridones
1
2016
18
0.150
Why?
Nutrition Assessment
1
2017
52
0.150
Why?
Thiazoles
1
2016
38
0.150
Why?
Evidence-Based Medicine
1
2018
235
0.150
Why?
Evidence-Based Practice
1
2017
86
0.150
Why?
Pyridines
1
2016
47
0.150
Why?
Neoplasms
1
2020
280
0.150
Why?
Echocardiography
4
2023
207
0.150
Why?
Patient Selection
2
2020
261
0.150
Why?
Georgia
1
2016
16
0.140
Why?
Coronary Vessels
2
2021
56
0.140
Why?
Sensitivity and Specificity
2
2015
592
0.140
Why?
Pyrazoles
1
2016
53
0.140
Why?
Cholesterol, LDL
1
2016
46
0.140
Why?
Dementia
1
2022
568
0.140
Why?
Platelet Aggregation Inhibitors
1
2016
68
0.140
Why?
Diet, Mediterranean
1
2017
72
0.140
Why?
Health Surveys
1
2016
102
0.140
Why?
Self Efficacy
1
2016
66
0.140
Why?
Miniaturization
1
2015
2
0.140
Why?
Preventive Health Services
1
2015
16
0.140
Why?
Chicago
2
2016
957
0.140
Why?
Equipment Design
2
2015
207
0.130
Why?
Equipment Failure Analysis
1
2015
117
0.130
Why?
Heart Rate
2
2009
165
0.130
Why?
Smoking
2
2018
206
0.120
Why?
Needs Assessment
1
2013
50
0.120
Why?
Cardiac Pacing, Artificial
2
1992
84
0.110
Why?
Drug Monitoring
1
2012
28
0.110
Why?
Heart Conduction System
1
1992
38
0.110
Why?
Activities of Daily Living
1
2016
515
0.110
Why?
Data Collection
1
2012
118
0.110
Why?
Registries
3
2022
226
0.110
Why?
Blood Pressure
2
2023
270
0.100
Why?
Motor Activity
1
2013
391
0.090
Why?
Coronary Artery Bypass
2
2020
74
0.090
Why?
Survival Rate
2
2019
443
0.080
Why?
Databases, Factual
2
2019
393
0.080
Why?
Azetidines
1
2006
4
0.070
Why?
Benzylamines
1
2006
15
0.070
Why?
Severity of Illness Index
2
2021
1242
0.070
Why?
Body Mass Index
2
2020
478
0.070
Why?
Time Factors
3
2021
1873
0.070
Why?
Endpoint Determination
1
2004
31
0.070
Why?
Blood Pressure Monitoring, Ambulatory
1
2023
7
0.060
Why?
Pharmacists
1
2023
19
0.060
Why?
Postoperative Complications
2
2020
1117
0.060
Why?
Urokinase-Type Plasminogen Activator
1
2022
15
0.060
Why?
Follow-Up Studies
2
2019
2053
0.060
Why?
Flecainide
1
2021
14
0.050
Why?
Double-Blind Method
2
2006
546
0.050
Why?
Microcirculation
1
2021
40
0.050
Why?
Genetic Testing
1
2022
77
0.050
Why?
Ischemia
1
2021
35
0.050
Why?
Palliative Care
1
2023
158
0.050
Why?
Pregnancy, High-Risk
1
2021
2
0.050
Why?
Peripartum Period
1
2021
3
0.050
Why?
Delivery of Health Care
1
2023
166
0.050
Why?
Chlorides
1
2021
26
0.050
Why?
Diuretics
1
2021
15
0.050
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
104
0.050
Why?
Recurrence
2
2006
400
0.050
Why?
Health Services Research
1
2021
44
0.050
Why?
Sodium
1
2021
87
0.050
Why?
Education, Medical
1
2021
48
0.050
Why?
Vascular Endothelial Growth Factor A
1
2020
71
0.050
Why?
Patient Preference
1
2021
38
0.050
Why?
Fetal Growth Retardation
1
2020
4
0.050
Why?
Hypercholesterolemia
1
2020
39
0.050
Why?
Polycystic Ovary Syndrome
1
2020
4
0.050
Why?
Abortion, Spontaneous
1
2020
9
0.050
Why?
Menopause, Premature
1
2020
7
0.050
Why?
Sleep Apnea, Central
1
2000
26
0.050
Why?
Lactation
1
2021
79
0.050
Why?
Case-Control Studies
2
2000
694
0.050
Why?
Health Care Costs
1
2020
83
0.050
Why?
Attitude to Health
1
2020
116
0.050
Why?
Radiotherapy
1
2020
62
0.050
Why?
Curriculum
1
2021
173
0.050
Why?
Costs and Cost Analysis
1
2019
39
0.050
Why?
Autoimmune Diseases
1
2020
67
0.040
Why?
Cause of Death
1
2019
83
0.040
Why?
Thrombectomy
1
2019
53
0.040
Why?
Multivariate Analysis
1
2020
386
0.040
Why?
Disease Management
1
2020
138
0.040
Why?
Psychology
1
2018
24
0.040
Why?
Health Services Needs and Demand
1
2018
70
0.040
Why?
Heredity
1
2018
7
0.040
Why?
Diet, Western
1
2017
8
0.040
Why?
Diabetes Mellitus, Type 2
1
2020
230
0.040
Why?
Quality Improvement
1
2018
173
0.040
Why?
Breast Feeding
1
2018
186
0.040
Why?
Waist Circumference
1
2015
37
0.040
Why?
Risk
1
2016
228
0.030
Why?
Drug Therapy, Combination
1
2016
261
0.030
Why?
Body Composition
1
2016
78
0.030
Why?
Body Weight
1
2016
167
0.030
Why?
Decision Making
1
2018
239
0.030
Why?
Genetic Predisposition to Disease
1
2018
467
0.030
Why?
Patient Compliance
1
2016
200
0.030
Why?
Wolff-Parkinson-White Syndrome
1
1993
3
0.030
Why?
Dextroamphetamine
1
1993
6
0.030
Why?
Social Networking
1
2013
10
0.030
Why?
Hypotension, Orthostatic
1
1993
17
0.030
Why?
Efficiency
1
2013
21
0.030
Why?
Syncope
1
1993
11
0.030
Why?
Albuterol
1
1993
20
0.030
Why?
Bradycardia
1
1993
32
0.030
Why?
Interviews as Topic
1
2013
152
0.030
Why?
Program Evaluation
1
2013
150
0.030
Why?
Tachycardia, Ventricular
1
1992
44
0.030
Why?
Cardiac Catheterization
1
1992
116
0.030
Why?
Asthma
1
1993
194
0.020
Why?
Animals
1
2020
5371
0.020
Why?
Estrogen Replacement Therapy
1
2006
22
0.020
Why?
Thromboembolism
1
2006
38
0.020
Why?
Chi-Square Distribution
1
2006
177
0.020
Why?
Proportional Hazards Models
1
2006
387
0.020
Why?
Combined Modality Therapy
1
2004
449
0.010
Why?
Electrocardiography, Ambulatory
1
2000
24
0.010
Why?
Bronchoscopy
1
2000
38
0.010
Why?
Respiration
1
2000
37
0.010
Why?
Tracheostomy
1
2000
28
0.010
Why?
Anesthesia
1
2000
35
0.010
Why?
Child
1
2000
1634
0.010
Why?
False Positive Reactions
1
1993
38
0.010
Why?
Administration, Inhalation
1
1993
42
0.010
Why?
Posture
1
1993
90
0.010
Why?
Action Potentials
1
1993
151
0.010
Why?
ROC Curve
1
1992
155
0.010
Why?
Analysis of Variance
1
1992
358
0.010
Why?
Volgman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description